Pharma & Healthcare

Global Sarcopenia Treatments Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

In 2024, the global market size of Sarcopenia Treatments was estimated to be worth US$ 3021 million and is forecast to reach approximately US$ 4120 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatments.
The Sarcopenia Treatments market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sarcopenia Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Segment by Type
Protein Supplement
Calcium Supplement
Other
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Sarcopenia Treatments in global and regional level.
Chapter 3: Detailed analysis of Sarcopenia Treatments company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sarcopenia Treatments revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Sarcopenia Treatments Product Introduction
1.2 Market by Type
1.2.1 Global Sarcopenia Treatments Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Treatments Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sarcopenia Treatments Market Size Estimates and Forecasts
2.2 Sarcopenia Treatments Market Size by Region: 2024 Versus 2031
2.2.1 Global Sarcopenia Treatments Revenue by Region: 2020-2025
2.2.2 Global Sarcopenia Treatments Revenue Forecast by Region (2026-2031)
2.2.3 Global Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sarcopenia Treatments Revenue by Type (2020-2031)
3.1.2 Global Sarcopenia Treatments Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sarcopenia Treatments Revenue by Application (2020-2031)
3.2.2 Global Sarcopenia Treatments Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Protein Supplement of Sarcopenia Treatments Revenue Market Share by Application
3.3.2 Calcium Supplement of Sarcopenia Treatments Revenue Market Share by Application
3.3.3 Other of Sarcopenia Treatments Revenue Market Share by Application
4 Global Sarcopenia Treatments by Company
4.1 Global Sarcopenia Treatments Revenue by Company (2020-2025)
4.2 Global Sarcopenia Treatments Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Sarcopenia Treatments Companies around the World: Ranking by Revenue
4.3.2 Global Sarcopenia Treatments Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Sarcopenia Treatments Companies Headquarters & Product Type
4.4.1 Global Sarcopenia Treatments Companies Headquarters
4.4.2 Date of International Companies Enter into Sarcopenia Treatments Market
4.4.3 Global Sarcopenia Treatments Companies Product & Service
4.4.4 Protein Supplement Revenue Market Share of Sarcopenia Treatments by Company
4.4.5 Calcium Supplement Revenue Market Share of Sarcopenia Treatments by Company
4.4.6 Other Revenue Market Share of Sarcopenia Treatments by Company
4.5 Global Sarcopenia Treatments Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Corporation Information
5.1.2 Abbott Laboratories Description, Business Overview
5.1.3 Abbott Laboratories Sarcopenia Treatments Products Offered
5.1.4 Abbott Laboratories Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.1.5 Abbott Laboratories Sarcopenia Treatments Revenue by Product in 2024
5.1.6 Abbott Laboratories Sarcopenia Treatments Revenue by Application in 2024
5.1.7 Abbott Laboratories Sarcopenia Treatments Revenue by Geographic Area in 2024
5.1.8 Abbott Laboratories Recent Developments
5.2 Nestlé
5.2.1 Nestlé Corporation Information
5.2.2 Nestlé Description, Business Overview
5.2.3 Nestlé Sarcopenia Treatments Products Offered
5.2.4 Nestlé Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.2.5 Nestlé Sarcopenia Treatments Revenue by Product in 2024
5.2.6 Nestlé Sarcopenia Treatments Revenue by Application in 2024
5.2.7 Nestlé Sarcopenia Treatments Revenue by Geographic Area in 2024
5.2.8 Nestlé Recent Developments
5.3 Pfizer
5.3.1 Pfizer Corporation Information
5.3.2 Pfizer Description, Business Overview
5.3.3 Pfizer Sarcopenia Treatments Products Offered
5.3.4 Pfizer Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.3.5 Pfizer Sarcopenia Treatments Revenue by Product in 2024
5.3.6 Pfizer Sarcopenia Treatments Revenue by Application in 2024
5.3.7 Pfizer Sarcopenia Treatments Revenue by Geographic Area in 2024
5.3.8 Pfizer Recent Developments
5.4 Amway
5.4.1 Amway Corporation Information
5.4.2 Amway Description, Business Overview
5.4.3 Amway Sarcopenia Treatments Products Offered
5.4.4 Amway Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.4.5 Amway Sarcopenia Treatments Revenue by Product in 2024
5.4.6 Amway Sarcopenia Treatments Revenue by Application in 2024
5.4.7 Amway Sarcopenia Treatments Revenue by Geographic Area in 2024
5.4.8 Amway Recent Developments
5.5 By-health
5.5.1 By-health Corporation Information
5.5.2 By-health Description, Business Overview
5.5.3 By-health Sarcopenia Treatments Products Offered
5.5.4 By-health Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.5.5 By-health Sarcopenia Treatments Revenue by Product in 2024
5.5.6 By-health Sarcopenia Treatments Revenue by Application in 2024
5.5.7 By-health Sarcopenia Treatments Revenue by Geographic Area in 2024
5.5.8 By-health Recent Developments
5.6 Usana
5.6.1 Usana Corporation Information
5.6.2 Usana Description, Business Overview
5.6.3 Usana Sarcopenia Treatments Products Offered
5.6.4 Usana Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.6.5 Usana Sarcopenia Treatments Revenue by Product in 2024
5.6.6 Usana Sarcopenia Treatments Revenue by Application in 2024
5.6.7 Usana Sarcopenia Treatments Revenue by Geographic Area in 2024
5.6.8 Usana Recent Developments
5.7 A&Z Pharmaceutical
5.7.1 A&Z Pharmaceutical Corporation Information
5.7.2 A&Z Pharmaceutical Description, Business Overview
5.7.3 A&Z Pharmaceutical Sarcopenia Treatments Products Offered
5.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.7.5 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Product in 2024
5.7.6 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Application in 2024
5.7.7 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Geographic Area in 2024
5.7.8 A&Z Pharmaceutical Recent Developments
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Corporation Information
5.8.2 GlaxoSmithKline Description, Business Overview
5.8.3 GlaxoSmithKline Sarcopenia Treatments Products Offered
5.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.8.5 GlaxoSmithKline Sarcopenia Treatments Revenue by Product in 2024
5.8.6 GlaxoSmithKline Sarcopenia Treatments Revenue by Application in 2024
5.8.7 GlaxoSmithKline Sarcopenia Treatments Revenue by Geographic Area in 2024
5.8.8 GlaxoSmithKline Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Sarcopenia Treatments Products Offered
5.9.4 Bayer Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Sarcopenia Treatments Revenue by Product in 2024
5.9.6 Bayer Sarcopenia Treatments Revenue by Application in 2024
5.9.7 Bayer Sarcopenia Treatments Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 H&H
5.10.1 H&H Corporation Information
5.10.2 H&H Description, Business Overview
5.10.3 H&H Sarcopenia Treatments Products Offered
5.10.4 H&H Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.10.5 H&H Sarcopenia Treatments Revenue by Product in 2024
5.10.6 H&H Sarcopenia Treatments Revenue by Application in 2024
5.10.7 H&H Sarcopenia Treatments Revenue by Geographic Area in 2024
5.10.8 H&H Recent Developments
5.11 Blackmores
5.11.1 Blackmores Corporation Information
5.11.2 Blackmores Description, Business Overview
5.11.3 Blackmores Sarcopenia Treatments Products Offered
5.11.4 Blackmores Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.11.5 Blackmores Sarcopenia Treatments Revenue by Product in 2024
5.11.6 Blackmores Sarcopenia Treatments Revenue by Application in 2024
5.11.7 Blackmores Sarcopenia Treatments Revenue by Geographic Area in 2024
5.11.8 Blackmores Recent Developments
5.12 Zhendong Group
5.12.1 Zhendong Group Corporation Information
5.12.2 Zhendong Group Description, Business Overview
5.12.3 Zhendong Group Sarcopenia Treatments Products Offered
5.12.4 Zhendong Group Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.12.5 Zhendong Group Sarcopenia Treatments Revenue by Product in 2024
5.12.6 Zhendong Group Sarcopenia Treatments Revenue by Application in 2024
5.12.7 Zhendong Group Sarcopenia Treatments Revenue by Geographic Area in 2024
5.12.8 Zhendong Group Recent Developments
6 North America
6.1 North America Sarcopenia Treatments Market Size YoY Growth 2020-2031
6.2 North America Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
6.3 North America Sarcopenia Treatments Revenue by Type (2020-2025)
6.4 North America Sarcopenia Treatments Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sarcopenia Treatments Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sarcopenia Treatments Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Sarcopenia Treatments Revenue by Type (2020-2025)
7.4 Asia-Pacific Sarcopenia Treatments Revenue by Application (2020-2025)
8 Europe
8.1 Europe Sarcopenia Treatments Market Size YoY Growth 2020-2031
8.2 Europe Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
8.3 Europe Sarcopenia Treatments Revenue by Type (2020-2025)
8.4 Europe Sarcopenia Treatments Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Sarcopenia Treatments Market Size YoY Growth 2020-2031
9.2 Latin America Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
9.3 Latin America Sarcopenia Treatments Revenue by Type (2020-2025)
9.4 Latin America Sarcopenia Treatments Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sarcopenia Treatments Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Sarcopenia Treatments Revenue by Type (2020-2025)
10.4 Middle East and Africa Sarcopenia Treatments Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sarcopenia Treatments Supply Chain Analysis
11.2 Sarcopenia Treatments Key Raw Materials and Upstream Suppliers
11.3 Sarcopenia Treatments Clients Analysis
11.4 Sarcopenia Treatments Sales Channel and Sales Model Analysis
11.4.1 Sarcopenia Treatments Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sarcopenia Treatments Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sarcopenia Treatments Distributors
12 Sarcopenia Treatments Market Dynamics
12.1 Sarcopenia Treatments Industry Trends
12.2 Sarcopenia Treatments Market Drivers
12.3 Sarcopenia Treatments Market Challenges
12.4 Sarcopenia Treatments Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Sarcopenia Treatments Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Sarcopenia Treatments Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Sarcopenia Treatments Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Sarcopenia Treatments Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sarcopenia Treatments Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Sarcopenia Treatments Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Sarcopenia Treatments Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Sarcopenia Treatments Revenue by Company (2020-2025) & (US$ Million)
Table 11. Sarcopenia Treatments Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Sarcopenia Treatments Players by Revenue (US$ Million) in 2024
Table 13. Global Sarcopenia Treatments Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Sarcopenia Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Treatments as of 2024)
Table 15. Global Sarcopenia Treatments Companies Headquarters
Table 16. Date of International Companies Enter into Sarcopenia Treatments Market
Table 17. Global Sarcopenia Treatments Companies Product & Service
Table 18. Global Sarcopenia Treatments Mergers & Acquisitions, Expansion Plans
Table 19. Abbott Laboratories Corporation Information
Table 20. Abbott Laboratories Description and Business Overview
Table 21. Abbott Laboratories Sarcopenia Treatments Product
Table 22. Abbott Laboratories Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 24. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 25. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 26. Abbott Laboratories Recent Developments
Table 27. Nestlé Corporation Information
Table 28. Nestlé Description and Business Overview
Table 29. Nestlé Sarcopenia Treatments Product
Table 30. Nestlé Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Nestlé Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 32. Nestlé Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 33. Nestlé Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 34. Nestlé Recent Developments
Table 35. Pfizer Corporation Information
Table 36. Pfizer Description and Business Overview
Table 37. Pfizer Sarcopenia Treatments Product
Table 38. Pfizer Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Pfizer Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 40. Pfizer Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 41. Pfizer Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 42. Pfizer Recent Developments
Table 43. Amway Corporation Information
Table 44. Amway Description and Business Overview
Table 45. Amway Sarcopenia Treatments Product
Table 46. Amway Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Amway Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 48. Amway Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 49. Amway Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 50. Amway Recent Developments
Table 51. By-health Corporation Information
Table 52. By-health Description and Business Overview
Table 53. By-health Sarcopenia Treatments Product
Table 54. By-health Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. By-health Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 56. By-health Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 57. By-health Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 58. By-health Recent Developments
Table 59. Usana Corporation Information
Table 60. Usana Description and Business Overview
Table 61. Usana Sarcopenia Treatments Product
Table 62. Usana Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Usana Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 64. Usana Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 65. Usana Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 66. Usana Recent Developments
Table 67. A&Z Pharmaceutical Corporation Information
Table 68. A&Z Pharmaceutical Description and Business Overview
Table 69. A&Z Pharmaceutical Sarcopenia Treatments Product
Table 70. A&Z Pharmaceutical Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 72. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 73. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 74. A&Z Pharmaceutical Recent Developments
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Sarcopenia Treatments Product
Table 78. GlaxoSmithKline Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 80. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 81. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 82. GlaxoSmithKline Recent Developments
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Sarcopenia Treatments Product
Table 86. Bayer Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Bayer Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 88. Bayer Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 89. Bayer Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 90. Bayer Recent Developments
Table 91. H&H Corporation Information
Table 92. H&H Description and Business Overview
Table 93. H&H Sarcopenia Treatments Product
Table 94. H&H Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. H&H Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 96. H&H Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 97. H&H Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 98. H&H Recent Developments
Table 99. Blackmores Corporation Information
Table 100. Blackmores Description and Business Overview
Table 101. Blackmores Sarcopenia Treatments Product
Table 102. Blackmores Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Blackmores Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 104. Blackmores Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 105. Blackmores Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 106. Blackmores Recent Developments
Table 107. Zhendong Group Corporation Information
Table 108. Zhendong Group Description and Business Overview
Table 109. Zhendong Group Sarcopenia Treatments Product
Table 110. Zhendong Group Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Product in 2024
Table 112. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Application in 2024
Table 113. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
Table 114. Zhendong Group Recent Developments
Table 115. North America Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Sarcopenia Treatments Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Sarcopenia Treatments Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
Table 135. Sarcopenia Treatments Key Raw Materials, Industry Status and Trend
Table 136. Sarcopenia Treatments Key Raw Materials and Upstream Suppliers
Table 137. Sarcopenia Treatments Clients Status and Trend
Table 138. Sarcopenia Treatments Typical Clients
Table 139. Sarcopenia Treatments Distributors
Table 140. Sarcopenia Treatments Market Trends
Table 141. Sarcopenia Treatments Market Drivers
Table 142. Sarcopenia Treatments Market Challenges
Table 143. Sarcopenia Treatments Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources


List of Figures
Figure 1. Sarcopenia Treatments Product Picture
Figure 2. Global Sarcopenia Treatments Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Sarcopenia Treatments Revenue Market Share by Type in 2024 & 2031
Figure 4. Protein Supplement Product Picture
Figure 5. Calcium Supplement Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sarcopenia Treatments Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Sarcopenia Treatments Revenue Market Share by Application in 2024 & 2031
Figure 9. Online Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Sarcopenia Treatments Report Years Considered
Figure 12. Global Sarcopenia Treatments Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sarcopenia Treatments Market Size (2020-2031) & (US$ Million)
Figure 14. Global Sarcopenia Treatments Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
Figure 16. Global Sarcopenia Treatments Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Sarcopenia Treatments Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Protein Supplement of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
Figure 19. Calcium Supplement of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
Figure 20. Other of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
Figure 21. Sarcopenia Treatments Revenue Share by Company (2024)
Figure 22. Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Protein Supplement Revenue Proportion by Company in 2024
Figure 24. Calcium Supplement Revenue Proportion by Company in 2024
Figure 25. Other Revenue Proportion by Company in 2024
Figure 26. North America Sarcopenia Treatments Revenue 2020-2031 (US$ Million)
Figure 27. North America Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
Figure 28. North America Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Sarcopenia Treatments Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
Figure 33. Europe Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
Figure 35. Europe Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
Figure 36. Europe Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
Figure 45. Sarcopenia Treatments Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Sarcopenia Treatments Raw Materials by Region in 2024
Figure 47. Sarcopenia Treatments Distribution Channels
Figure 48. Global Sarcopenia Treatments Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Sarcopenia Treatments Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies